معرفی
Dr. Varman Samuel is an Associate Professor of Medicine (Endocrinology) and Section Chief of Endocrinology at the VA Connecticut Healthcare System. He is affiliated with Yale School of Medicine, where he holds academic positions within the Department of Medicine. His research focuses on the mechanisms linking insulin resistance, nonalcoholic fatty liver disease (NAFLD), and diabetes, particularly investigating fructose metabolism and lipid signaling pathways. He has contributed to VA/DOD clinical practice guidelines for Type 2 Diabetes Mellitus and collaborates widely with institutions like the Diabetes Research Center and Mouse Metabolic Phenotyping Center.
Education & Training:
- MD, NYU School of Medicine (1995)
- PhD, Yale University School of Medicine (2005)
- Residency and Fellowship at the University of Chicago Hospitals (1998–2000)
Research Interests: Dr. Samuel explores hepatic insulin resistance, NAFLD pathogenesis, and fructose-induced metabolic dysfunction. His lab uses rodent models to study lipid droplet cholesterol content, ceramide pathways, and mitochondrial dysfunction in metabolic diseases. Recent work includes investigating therapies targeting CIDEB, Coenzyme A synthase, and PKCε signaling.
Key Publications: Dr. Samuel's recent work emphasizes lipid metabolism's role in insulin resistance and liver disease. His 2025 study on liver lipid droplet cholesterol content highlights novel mechanisms in metabolic dysfunction-associated steatohepatitis (MAFLD). Other studies focus on high-fat diet effects, ceramide inhibitors, and lysophosphatidic acid in inflammation.
Awards & Grants: Though no specific awards are listed, his research has been supported by grants addressing diabetes, NAFLD, and metabolic pathways. Collaborations with Gerald Shulman and others underscore his team's interdisciplinary approach.
Labs & Teams: Active in the Diabetes Research Center and Mouse Metabolic Phenotyping Center, his work integrates basic science with clinical insights to advance therapies for metabolic disorders.